Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
John Neis
AddedMar 31, 2024
UpdatedMay 1, 2026
John Neis

John Neis

Co-Founder, Venture Investors

John Neis's Career

Venture Investors
Venture Investors

Madison, WI, US

Co-Founder
Mithridion
Mithridion

Madison, WI, US

Board Member· Board
TAI Diagnostics
TAI Diagnostics

Wauwatosa, WI, US

Board Member· Board
Deltanoid Pharmaceuticals
Deltanoid Pharmaceuticals

Madison, WI, US

Board Member· Board
Delphinus Medical Technologies
Delphinus Medical Technologies

Plymouth, MI, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

John Neis's Career

Venture Investors
Venture Investors
Investment FirmInvestment Firm181997Madison, WI, US
Co-Founder

Leadership at Venture Investors

Roger GanserRoger GanserCo-Founder
Mithridion
Mithridion
Series C$6.4M72004Madison, WI, US
Board Member· Board

Leadership at Mithridion

Paul WeissPaul WeissBoard Member
Fred RobertsonFred RobertsonBoard Member
Wayne HossWayne HossBoard Member
Trevor TwoseTrevor TwoseBoard Member
TAI Diagnostics
TAI Diagnostics
Series A$29M112013Wauwatosa, WI, US
Board Member· Board

Leadership at TAI Diagnostics

Michael MitchellMichael MitchellCo-Founder
Aoy Tomita-MitchelAoy Tomita-MitchelCo-Founder
John C FowlerJohn C FowlerBoard Member
Frank LangleyFrank LangleyCEO

Similar to TAI Diagnostics

Test DiagnosticsTest DiagnosticsNew York City, NY, USDiagnostics, Medical DevicesTest DiagnosticsNew York City, NY, US

NYC-based Test Diagnostics develops Point-of-Care diagnostic technology.

Seed · $334k2
Empowered DiagnosticsEmpowered DiagnosticsPompano Beach, FL, USDiagnostic Testsest. 2017Empowered DiagnosticsPompano Beach, FL, US · est. 2017

Empowered Diagnostics: Reliable, affordable, high-quality diagnostic tests for informed health decisions.

Seed · $4.7M13
CareDxCareDxBrisbane, CA, USDiagnostics, Testingest. 1999CareDxBrisbane, CA, US · est. 1999

CareDx, Inc., a California-based medical firm, specializes in molecular diagnostics for transplant medicine and autoimmunity.

Public · $574.9M770
Eclipse DiagnosticsEclipse DiagnosticsLos Angeles, CA, USDiagnostics, Test Kitsest. 2018Eclipse DiagnosticsLos Angeles, CA, US · est. 2018

Eclipse Diagnostics: Innovating biotech solutions for home and field-test diagnostics.

Angel · $350.8k5
Deltanoid Pharmaceuticals
Deltanoid Pharmaceuticals
Public$16M111999Madison, WI, US
Board Member· Board

Leadership at Deltanoid Pharmaceuticals

Margaret Clagett-DameMargaret Clagett-DameBoard Member
Hector F. DeLucaHector F. DeLucaBoard Member
Lori A PlumLori A PlumBoard Member
Jim DomachJim DomachBoard Member
P Loreen MershimerP Loreen MershimerBoard Member

Similar to Deltanoid Pharmaceuticals

NeuroTherapeutics PharmaNeuroTherapeutics PharmaChicago, IL, USPharmaceuticals, Therapeuticsest. 2006NeuroTherapeutics PharmaChicago, IL, US · est. 2006

NeuroTherapeutics Pharma: A US-based biopharmaceutical firm specializing in neuropathic and acute pain treatments.

Public · $60.7M30
KinDex PharmaceuticalsKinDex PharmaceuticalsSeattle, WA, USTherapeuticsest. 2009KinDex PharmaceuticalsSeattle, WA, US · est. 2009

KinDex Pharmaceuticals develops novel therapeutics for metabolic disorder treatment.

Angel · $5.8M10
Transport PharmaceuticalsTransport PharmaceuticalsFramingham, MA, USMedical Devices, Pharmaceuticalsest. 1999Transport PharmaceuticalsFramingham, MA, US · est. 1999

Transport Pharmaceuticals develops drug/device combos for dermal diseases, including acne, psoriasis, and herpes.

Angel · $1.8M275
Zosano PharmaZosano PharmaFremont, CA, USBiopharmaceuticals, Vaccinesest. 2006Zosano PharmaFremont, CA, US · est. 2006

Zosano Pharma Corp. specializes in biopharmaceuticals and vaccines for severe osteoporosis treatment.

Public · $271.9M56
Delphinus Medical Technologies
Delphinus Medical Technologies
Series A$109.1M752010Plymouth, MI, US
Board Member· Board

Leadership at Delphinus Medical Technologies

Michael GrossMichael GrossBoard Member
Rachel BremRachel BremBoard Member
Neb DuricNeb DuricCo-Founder
Eyal MalingerEyal MalingerBoard Member
Peter LittrupPeter LittrupCo-Founder
Mark J ForchetteMark J ForchetteCEO

Similar to Delphinus Medical Technologies

DeepSight TechnologyDeepSight TechnologySan Francisco, CA, USMedical Imagingest. 2019DeepSight TechnologySan Francisco, CA, US · est. 2019

Revolutionizing diagnostic medical imaging with DeepSight™ Technology for safer, faster, and affordable solutions.

Series A · $25M33
Dilon TechnologiesDilon TechnologiesNewport News, VA, USMedical Imagingest. 1997Dilon TechnologiesNewport News, VA, US · est. 1997

Dilon Technologies, based in Newport News, US, provides molecular imaging for early cancer detection.

Series A · $9.5M48
Mirabilis MedicaMirabilis MedicaBothell, WA, USMedical Devicesest. 2006Mirabilis MedicaBothell, WA, US · est. 2006

Mirabilis Medica designs therapeutic ultrasound devices for uterine fibroids treatment in the US.

Angel · $29.1M8
SonositeSonositeBothell, WA, USUltrasound Systemsest. 1998SonositeBothell, WA, US · est. 1998

SonoSite, Inc.: Innovating portable ultrasound technology for efficient, affordable, and accessible diagnostics worldwide.

Public750

John Neis's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to John Neis

Chris NeilChris NeilCo-Founder · Maxim VenturesGreg DraconGreg DraconBoard Member · TausightBrian JacobsBrian JacobsBoard Member · InsideView TechnologiesStephen KrausStephen KrausBoard Member · New England Venture Capital AssociationNeel MehtaNeel MehtaCo-Founder · EpiFinderLee FentressLee FentressCo-Founder · Pledge